Pharmacokinetics, Metabolism, and Toxicology of Dichloroacetate

References

• Moore R. E. Volatile compounds from marine algae. Acc. Chem. Res. 1977; 10: 40–47
   Web of Science ®Google Scholar
• Wannstedt C., Rotella D., Siuda J. F. Chloroperoxidase mediated halogenation of phenols. Bull. Environ. Contam. Toxicol. 1990; 44: 282–287
   PubMed Web of Science ®Google Scholar
• Gribble G. W. Naturally occurring organo-halogen compounds—a survey. J. Nat. Prod. 1992; 55: 1353–1395
   Web of Science ®Google Scholar
• Goldman P., Milne G. W. A., Pignataro M. T. Fluorine containing metabolites formed from 2-fluorobenzoic acid by Pseudomonas species. Arch. Biochem. Biophys. 1967; 118: 178–184
   Web of Science ®Google Scholar
• Wuosmaa A. M., Hager L. P. Methylchloride transferase: a carbocation route for biosynthesis of halometabolites. Science 1990; 249: 160–162
   PubMed Web of Science ®Google Scholar
• Valli K., Gold M. H. Degradation of 2,4-dichlorophenol by the lignin-degrading fungus. Phanerochate chrysosporium, J. Bacteriol. 1991; 173: 345–352
   PubMed Web of Science ®Google Scholar
• Weightman A. J., Weightman A. L., Slater J. H. Toxic effects of chlorinated and brominated alkanoic acids on Pseudomonas putida PP3: selection at high frequencies of mutations in genes encoding dehalogenases. Appl. Environ. Microbiol. 1985; 49: 1494–1501
   PubMed Web of Science ®Google Scholar
• Taurog A. Hormone synthesis: thyroid iodine metabolism. The Thyroid: A Fundamental and Clinical Text, 5th ed., S. H. Inbar, L. E. Braverman. J. B. Lippincott, Philadelphia 1986; 53–97
   Google Scholar
• Miller J. W., Uden P. C. Characterization of nonvolatile aqueous chlorination products of humic substances. Environ. Sci. Technol. 1983; 17: 150–157
   PubMed Web of Science ®Google Scholar
• Uden P. C., Miller J. W. Chlorinated acids and chloral in drinking water. J. Am. Water Works Assoc. 1983; 75: 524–527
   Web of Science ®Google Scholar
• Mughal F. H. Chlorination of drinking water and cancer: a review. J Environ. Pathol. Toxicol. Oncol. 1992; 11: 287–292
   PubMedGoogle Scholar
• Jolley R. L. Basic issues in water chlorination: a chemical perspective. Water Chlorination: Chemistry, Environmental Impact and Health Effects. Lewis Publ., Inc., Chelsea, MI 1985; Vol. 5: 19–38
   Google Scholar
• Stacpoole P. W. The pharmacology of dichloroacetate. Metabolism 1989; 38: 1124–1144
   PubMed Web of Science ®Google Scholar
• Abbas R. R., Seckel C. S., Kidney J. K., Fisher J. W. Pharmacokinetic analysis of chloral hydrate and its metabolism in B6C3F1 mice. Drug Metab. Disp. 1996; 24: 1340–1346
   PubMed Web of Science ®Google Scholar
• Henderson G. N., Yan Z., James M. O., Davydova N., Stacpoole P. W. Kinetics and metabolism of chloral hydrate in children: identification of dichloroacetate as a metabolite. Biochem. Biophys. Res. Commun. 1997; 235: 695–698
   PubMed Web of Science ®Google Scholar
• Ohta K., Takagi M. Antimicrobial compounds of the marine red alga. Marginisporum aberrans, Phytochemistry 1977; 16: 1085–1086
   Web of Science ®Google Scholar
• Stacpoole P. W. Review of the pharmacologic and therapeutic effects of diisopropylammonium dichloroacetate (DIPA). J. Clin. Pharmacol. 1969; 9: 282–291
   Web of Science ®Google Scholar
• Stacpoole P. W., Iwamoto E., Glasgow C. E. Diisopropylammonium dichloroacetate (DIPA): reversible antagonism towards smooth muscle stimulants and inhibition of acetylcholinesterase in the isolated guinea pig ileum. Res. Commun. Chem. Pathol. Pharmacol. 1971; 2: 439–446
   PubMedGoogle Scholar
• Stacpoole P. W., Moore G. W., Kornhauser D. M. Metabolic effects of dichloroacetate in patients with diabetes mellitus and hyperlipoproteinemia. N. Engl. J. Med. 1978; 298: 526–530
   PubMed Web of Science ®Google Scholar
• Moore G. W., Swift L. L., Rabinowitz D., Crofford O. B., Oates J. A., Stacpoole P. W. Reduction of serum cholesterol in two patients with homozygous familial hypercholesterolemia by dichloroacetate. Atherosclerosis 1979; 33: 285–293
   PubMed Web of Science ®Google Scholar
• Stacpoole P. W., Barnes C. L., Hurbanis M. D., Cannon S. L., Kerr D. S. Treatment of congenital lactic acidosis with dichloroacetate: a review. Arch. Dis. Child, (in press)
   PubMed Web of Science ®Google Scholar
• Wargovich T. I., Mac Donald R. G., Hill J. A., Feldman R. L., Stacpoole P. W., Pepine C. J. Myocardial metabolic and hemodynamic effects of dichloroacetate in patients with coronary artery disease. Am. J. Cardiol. 1989; 61: 65–70
   Web of Science ®Google Scholar
• Bersin R. M., Wolfe C., Kwasman M., Lau D., Klinski C., Tanaka K., Khorrami P., Henderson N., De Marco T., Chatterjee K. Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate. J. Am. Coll. Cardiol. 1994; 23: 1617–1624
   PubMed Web of Science ®Google Scholar
• Stacpoole P. W., Harman E. M., Curry S. H., Baumgartner T. G., Misbin R. I. Treatment of patients with lactic acidosis with dichloroacetate. N. Engl. J. Med. 1983; 309: 390–396
   PubMed Web of Science ®Google Scholar
• Stacpoole P. W., Wright E. C., Baumgartner T. G., Bersin R. M., Buchalter S., Curry S. H., Duncan C., Hackett R., Harman E. M., Hender G. N., Jenkinson S., Lachin J. M., Schneider S., Siegel J., Summer W. R., Thompson D., Wolfe C. and the DCA–Lactic Acidosis Study Group, A controlled trial of dichloroacetate treatment in patients with lactic acidosis. N. Engl. J. Med. 1992; 327: 1564–1569
   PubMed Web of Science ®Google Scholar
• Irsigler K., Kaspar L., Kritz H. Dichloroacetate in biguanide-induced lacticacidosis. Lancet 1977; 2: 1026–1027
   PubMed Web of Science ®Google Scholar
• Irsigler K., Brandle J., Kaspar I., Kritz H., Lageder H., Regal H. Treatment of biguanide-induced lactic acidosis with dichloroacetate. Arzneimittel-Forsch. 1979; 29: 555–559
   PubMed Web of Science ®Google Scholar
• Toth P. P., El-Shanti H., Eivens S., Rhead W. J., Klein J. M. Transient improvement of congenital lactic acidosis in a male infant with pyruvate decarboxylase deficiency treated with dichloroacetate. J. Pediatr. 1993; 23: 427–430
   Google Scholar
• Whitehouse S., Cooper R. H., Randle P. J. Mechanism of activation of pyruvate dehydrogenase by dichloroacetate and other halogenated carboxylic acids. Biochem. J. 1974; 141: 761–774
   PubMed Web of Science ®Google Scholar
• Stacpoole P. W. Lactic acidosis. lsndocrinol. Metab. Clin. North Am. 1993; 22: 221–245
   PubMed Web of Science ®Google Scholar
• Stacpoole P. W. Lactic acidosis and other mitochondrial disorders. Metabolism 1997; 46: 306–321
   PubMed Web of Science ®Google Scholar
• Curry S. H., Chu P.-I., Baumgartner T. G., Stacpoole P. W. Plasma concentrations and metabolic effects of intravenous sodium dichloroacetate. Clin. Pharmacol. Ther. 1985; 37: 89–93
   PubMed Web of Science ®Google Scholar
• Curry S. H., Lorenz A., Chu P.-I., Limacher M., Stacpoole P. W. Disposition and pharmacodynamics of dichloroacetate (DCA) and oxalate following oral DCA doses. Biopharm. Drug. Disp. 1991; 12: 375–390
   PubMed Web of Science ®Google Scholar
• Chu P.-I. Pharmacokinetics of sodium dichloroacetate. Ph.D. dissertation, University of Florida. 1987
   Google Scholar
• Wells P. G., Moore G. W., Rabin D., Wilkinson G. R., Oates J. A., Stacpoole P. W. Metabolic effects and pharmacokinetics of intravenously administered dichloroacetate in humans. Diabetologia 1980; 19: 109–113
   PubMed Web of Science ®Google Scholar
• Jackson V. N., Halestrap A. P. The kinetics, substrate, and inhibitor specificity of the monocarboxylate (lactate) transporter of rat liver cells determined using the fluorescent intracellular pH indicator, 2,7α-bis(carboxyethyl)-5(6)-carboxyfluroescein. J. Biol. Chem. 1996; 271: 861–868
   PubMed Web of Science ®Google Scholar
• Mc Allister A., Allison S. P., Randle P. J. Effects of dichloroacetate on the metabolism of glucose, pyruvate, acetate, 3-hydroxybutyrate and palmitate in rat diaphragm and heart muscle in vitro and on extraction of glucose, lactate, pyruvate and free fatty acids by dog heart in viro. Biochem. J. 1973; 134: 1067–1081
   PubMed Web of Science ®Google Scholar
• Larson J. L., Bull R. J. Metabolism and lipoperoxidase activity of tichloroacetate and dichloroacetate in rats and mice. Toxicol. Appl. Pharmacol. 1992; 115: 268–277
   PubMed Web of Science ®Google Scholar
• Yan Z., James M. O., Henderson G. N., Cornett R., Jayanti V. K. M. M., Davydova N., Stacpoole P. W. Pharmacokinetics and metabolism of dichloroacetate (DCA) in Sprague-Dawley rats: effect of age and diet. Superfund Basic Research Conference. February, 1997. Chapel Hill, NC
   Google Scholar
• Lukas G., Vyas K. H., Brindle S. D., Le Sher A. R., Wagner W. E., Jr. Biological disposition of sodium dichloroacetate in animals and humans after intravenous administration. J. Pharm. Sci. 1980; 69: 419–421
   PubMed Web of Science ®Google Scholar
• Krishna S., Supanaranond W., Pukrittayakamee S., Karter D., Supputamonkol Y., Davis T. M. E., Holloway P. A., White N. J. Dichloroacetate for lactic acidosis in severe malaria: a phartnacokinetic and pharmacodynamic assessment. Metabolism 1994; 43: 974–981
   PubMed Web of Science ®Google Scholar
• Krishna S., Supanaranond W., Pukrittayakamee S., Ter Kuile F., Ruprah M., White N. J. The disposition and effects of two doses of dichloroacetate in adults with severe falciparum malaria. Br. J. Clin. Pharmacol. 1996; 41: 29–34
   PubMed Web of Science ®Google Scholar
• Henderson G. N., Curry S. H., Derendorf H., Wright E. C., Stacpoole P. W. Pharmacokinetics of dichloroacetate in adult patients with lactic acidosis. J. Clin. Pharmacol. 1997; 37: 416–425
   PubMed Web of Science ®Google Scholar
• Curry S. H., Lorenz A., Henderson G. N., Mars D., Stacpoole P. W. Hemodialysis studies with dichloroacetate. Eur. J. Clin. Pharmacol. 1991; 40: 613–617
   PubMed Web of Science ®Google Scholar
• Shangraw R. E., Fisher D. M. Pharmacokinetics of dichloroacetate in patients undergoing liver transplantation. Anesthesiology 1996; 84: 851–858
   PubMed Web of Science ®Google Scholar
• Krishna S., Agbenyega T., Angus B. J., Bedu-Addo G., Ofori-Amanfo G., Henderson G., Szwandt I. S. F., O'Brien R., Stacpoole P. W. Pharmacokinetics and pharmacodynamics of dichloroacetate in children with lactic acidosis due to severe malaria. Q. J. Med. 1995; 88: 341–349
   Google Scholar
• Henderson G. N., Yan Z., James M. O., Stacpoole P. W. Kinetics and metabolism of dichloroacetate in healthy adult volunteers. Superfund Basic Research Conference. Chapel Hill, NC February, 1997
   Google Scholar
• Shangraw R. E., Winter R., Hromco J., Robinson S. T., Gallaher E. J. Amelioration of lactic acidosis with dichloroacetate during liver transplantation in humans. Anesthesiology 1994; 81: 1127–1138
   PubMed Web of Science ®Google Scholar
• Stacpoole P. W. Clinical trial of dichloroacetate as adjunct therapy in the treatment of severe malaria. 46th Annual Meeting of the American Society of TMAH, Orlando, December, 1997
   Google Scholar
• Caldwell J. Xenobiotic acyl-coenzymes A: critical intermediates in the biochemical pharmacology and toxicology of carboxylic acids. Biochem. Soc. Trans. 1984; 12: 84–86
   Google Scholar
• Sherratt H. S. A. Acyl-CoA esters of xenobiotic carboxylic acids as biochemically active intermediates. Biochem. Soc. Trans. 1985; 13: 856–858
   PubMed Web of Science ®Google Scholar
• Smith M. K., Randall I. L., Stober J. A., Read E. J. Developmental toxicity of dichloroacetonitrile: a by-product of drinking water disinfection. Fundam. Appl. Toxicol. 1989; 12: 765–772
   PubMedGoogle Scholar
• Stacpoole P. W., Harwood H. J., Jr., Varnado C. E. Regulation of rat liver hydroxymethylglutaryl coenzyme A reductase by a new class of noncompetitive inhibitors. Effects of dichloroacetate and related carboxylic acids on enzyme activity. J. Clin. Invest. 1983; 72: 1575–1585
   PubMed Web of Science ®Google Scholar
• Crabb D. W., Harris R. A. Mechanisms responsible for the hypoglycemic actions of dichloroacetate and 2-chloroproprionate. Arch. Biochem. Biophys. 1979; 198: 145–152
   PubMed Web of Science ®Google Scholar
• Lin E. L. C., Mattox J. K., Daniel F. B. Tissue distribution, excretion, and urinary metabolism of dichloroacetic-acid in the male Fischer 344 rat. J. Toxicol Environ. Health 1993; 38: 19–32
   PubMed Web of Science ®Google Scholar
• Pohl L. R., Nelson S. D., Krishna G. Investigation of the mechanism of the metabolic activation of chloramphenicol by rat liver microsomes. Identification of a new metabolite. Biochem. Pharmacol. 1978; 27: 491–496
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Cytochromes P-450. Comp. Biochem. Physiol. 1988; 89C: 1–4
   Google Scholar
• Halpert J. R., Guengerich F. P., Bend J. R., Correia M. A. Selective inhibitors of cytochromes P450. Toxicol. Appl. Pharmacol. 1994; 125: 163–175
   PubMed Web of Science ®Google Scholar
• Kaymans K., Donn G. M., Den Kelder é-Op, Koppele Te J. M., Vermenlen N. P. E. Cytochromes P450: their active-site structure and mechanism of oxidation. Drug Metab. Rev. 1993; 23: 325–387
   Google Scholar
• Yang H.-M., Houser W. H., Davis M. E. Dichloroacetic acid treatment increases hepatic CYP 2EI in male and female rats. Toxicol. Appl. Pharmacol. 1996; 141: 382–388
   PubMed Web of Science ®Google Scholar
• Yang H. M., Davis M. E., Berndt W. O. Dichloroacetic acid (DCA) potentiates chloroform-hepatoxicity by increasing CHC13 bioactivation. FASEB J. 1991; 5: A1564
   Web of Science ®Google Scholar
• Lipscomb J. C., Mahle D. A., Brashear W. T., Barton H. A. Dichloroacetic acid: metabolism in cytosol. Drug Metab. Disp. 1995; 23: 1202–1205
   PubMed Web of Science ®Google Scholar
• Cornett R., Yan Z., Henderson G., Stacpoole P. W., James M. O. Cytosolic biotransformation of dichloroacetic acid (DCA) in the Sprague-Dawley rat. Toxicologist 1997; 318
   Google Scholar
• Loew G., Trudell J., Motulsky H. Quantum chemical studies of the metabolism of a series of chlorinated ethane anesthetics. Molec. Pharmacol. 1973; 9: 152–162
   PubMed Web of Science ®Google Scholar
• Greenstein L. R., Hitt B. A., Mazze R. I. Metabolism in vitro of enflurane, isoflurane, and methoxyflurane. Anesthesiology 1975; 42: 420–424
   PubMed Web of Science ®Google Scholar
• Van Dyke R. A., Gandolfi A. J. Characteristics of a microsomal dechlorination system. Molec. Pharmacol. 1975; 11: 809–817
   PubMed Web of Science ®Google Scholar
• Guengerich F. P., Kim D.-H., Iwasaki M. Role of human cytochrome P-450 IIE 1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 1990; 4: 168–179
   Web of Science ®Google Scholar
• Jayyose Z., Knobel D., Muc M., Erick J., Thomas P. E., Kelley M. Cytochrome P-450 2E1 is not the sole catalyst of chlorzoxazone hydroxylation in rat liver microsomes. J. Pharmacol. Exp. Therap. 1995; 273: 1156–1161
   PubMed Web of Science ®Google Scholar
• Mi Y.-C., Wong T.-Y., Lloye R. V., Heinze T. M., Shelton S., Casciano D., Kadlubar F. F., Fu P. P. Mouse liver microsomal metabolism of chloral hydrate, trichloroacetic acid, and trichloroethanol leading to induction of lipid peroxidation via a free radical mechanism. Drug Metab. Disp. 1996; 24: 81–90
   PubMed Web of Science ®Google Scholar
• Connor H. D., Thurman R. G., Galizi M. D., Mason R. P. The formation of a novel free radical metabolite from CCI4 in the perfused rat liver and in vivo. J. Biol. Chem. 1986; 261: 4542–4548
   PubMed Web of Science ®Google Scholar
• Gibson G. G., Skett P. Introduction to Drug Metabolism, G. G. Gibson, P. Skett. Chapman & Hall, New York 1986
   Google Scholar
• Ketterer B., Mulder G. J. Glutathione conjugations. Conjugation Reactions in Drug Metabolism, G. J. Mulder. Taylor and Francis, London 1990; 307
   Google Scholar
• Durst H. D., Milano M., Kikta E. J., Jr., Connelly S. A., Grushka E. Phenacyl esters of fatty acids via crown ether catalysts for enhanced ultra-violet detection in liquid chromatography. Anal. Chem. 1975; 47: 1797–1801
   PubMed Web of Science ®Google Scholar
• Hiraoka M. Crown Compounds—Their Characteristics and Applications. Kodansha, Ltd., Tokyo/Elsevier Scientific Pub. Co., Amsterdam 1982
   Google Scholar
• Moore C., Pressman B. C. Mechanism of action of valinomycin on mitochondria. Biochem. Biophys. Res. Commun. 1962; 15: 565–567
   Google Scholar
• Riddell F. G., Tompsett S. J. The transport of Na and Kions through phospholipid bilayers mediated by the antibiotics salinomycin and narasin studies by 23Na- and 39K-NMR spectroscopy. Biochim. Biophys. Acta 1990; 1024: 193–197
   PubMed Web of Science ®Google Scholar
• Cramer F., Dieyschele W. Occlusion compounds. XVI. Stereo-specific reactions with inclusion compounds. Chem. Ber. 1959; 92: 1739–1747
   Google Scholar
• Griffiths D. W., Bender M. L. Cycloamyloses as catalysts. Adv. Catal. 1973; 23: 209–261
   Google Scholar
• Grunwald E., Winstein S. The role of neighboring groups in replacement reactions. XV. Rate and medium effects in the alcholysis and hydrolysis of α-bromopropionate ion. The carboxylate ion group. J. Am. Chem. Soc. 1948; 70: 841–846
   Web of Science ®Google Scholar
• Antolovic D., Shiver V. J., Davidson E. R. Theoretical study of alactone, acetoxyl diradical, and the gas-phase dissociation of the chloroacetate anion. J. Am. Chem. Soc. 1988; 110: 1375–1381
   Web of Science ®Google Scholar
• Rowsell E. V., Snell K., Carnie J. A., Rowsell K. V. The subcellular distribution of rat liver L-alanine-glyoxylate aminotransferase in relation to a pathway for glucose formation involving glyoxylate. Biochem. J. 1972; 127: 155–165
   PubMed Web of Science ®Google Scholar
• Jones D. P., Eklow L., Thor H., Orrenius S. Metabolism of hydrogen peroxide in isolated hepatocytes. Relative contributions of catalase and glutathione peroxidase in decomposition of endogenously generated H2O2. Arch. Biochem. Biophys. 1981; 210: 505–516
   PubMed Web of Science ®Google Scholar
• Stacpoole P. W. Diisopropylammonium dichloroacetate (DIPA) and sodium dichloroacetate (DCA): effects on intermediary metabolism in isolated rat liver parenchymal cells. Ph.D. dissertation, University of California, San Francisco 1972
   Google Scholar
• Huff J. W. Contact lens-induced edema in vitro. Invest. Ophthal. Vis. Sci. 1991; 32: 346–353
   PubMed Web of Science ®Google Scholar
• Hayes F. D., Short R. D., Gibson J. E. Differential toxicity of monochloroacetate, monofluoroacetate and monoiodoacetate in rats. Toxicol. Appl. Pharmacol. 1973; 26: 93–102
   PubMed Web of Science ®Google Scholar
• Mitroka J. G. Monochloroacetic acid lethality in the rat in relation to lactic acid accumulation in the cerebrospinal fluid. Ph.D. dissertation, University of Medicine and Dentistry of New Jersey, Newark 1989
   Google Scholar
• Anderson J. W., Karounos D., Yoneyama T. Dichloroacetate-induced changes in liver of normal and diabetic rats. Proc. Soc. Exp. Biol. Med. 1975; 149: 814–821
   PubMed Web of Science ®Google Scholar
• Herren-Freund S. L., Pereira M. A., Khoury M. D., Olson G. The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver. Toxicol. Appl. Pharmacol. 1987; 90: 183–189
   PubMed Web of Science ®Google Scholar
• Nelson M. A., Lansing A. J., Sanchez I. M., Bull R. J., Springer D. L. Dichloroacetic acid and trichloroacetic acid-induced DNA strand breaks are independent of peroxisome proliferation. Toxicology 1989; 58: 239–248
   PubMed Web of Science ®Google Scholar
• Bull R. J., Sanchez I. M., Nelson M. A., Larson J. L., Lansing A. J. Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. Toxocology 1990; 63: 341–359
   PubMed Web of Science ®Google Scholar
• Mather G. G., Exon J. H., Kohler L. D. Subchronic 90 day toxicity of dichloroacetic and trichloroacetic acids in rats. Toxicology 1990; 64: 71–80
   PubMed Web of Science ®Google Scholar
• Nelson M. A., Sanchez I. M., Bull R. J., Sylvester S. R. Increased expression of c-myc and c-H-ras in dichloroacetate and trichloroacetate-induced liver tumors in B6C3F1 mice. Toxicology 1990; 64: 47–57
   PubMed Web of Science ®Google Scholar
• Richmond R. E., De Angelo A. B., Lindahl R. Immunohistochemical localization of tumor-associated aldehyde dehydrogenase in formalinfixed rat and mouse normal liver and hepatomas. Histochem. J. 1990; 22: 527–529
   Google Scholar
• Sanchez I. M., Bull R. J. Early induction of reparative hyperplasia in the liver of B6C3F1 mice treated with dichloroacetate and dichloroacetate. Toxicology 1990; 64: 33–46
   PubMed Web of Science ®Google Scholar
• Cicmanec J. L., Condie L. W., Olson G. R., Wang S.-R. 90-day toxicity study of dichloroacetate in dogs. Fundam. Appl. Toxicol. 1991; 17: 376–389
   PubMedGoogle Scholar
• De Angelo A. B., Daniel F. B., Stober J. A., Olson G. R. The carcenogenicity of dichloroacetic acid in the male B6C3F1 mouse. Fundam. Appl. Toxicol. 1991; 16: 337–347
   PubMedGoogle Scholar
• Richmond R. E., De Angelo A. B., Potter E. L., Daniel F. B. The role of hyperplastic nodules in dichloroacetic acid-induced hepatocarcinogenesis in B6C3F1 male mice. Carcinogenesis 1991; 12: 1383–1387
   PubMed Web of Science ®Google Scholar
• Daniel F. B., De Angelo A. B., Stober J. A., Olsen G. R., Page N. P. Hepatocarcinogenicity of chloral hydrate, 2-chloroacetaldehyde, and dichloroacetic acid in the male B6C3F1 mouse. Fundam. Appl. Toxicol. 1992; 19: 159–168
   PubMedGoogle Scholar
• Davis M. E. Dichloroacetic acid and trichloroacetic acid increase chloroform toxicity. J. Toxicol. Environ. Health 1992; 37: 139–148
   PubMed Web of Science ®Google Scholar
• Smith M. K., Randall J. L., Read E. J., Stober J. A. Developmental toxicity of dichloroacetate in the rat. Teratology 1992; 46: 217–223
   PubMedGoogle Scholar
• Bruschi S. A., Bull R. J. In vitro cytotoxicity of mono-, di-, and trichloroacetate and its modulation by hepatic peroxisome proliferation. Fundam. Appl. Toxicol. 1993; 21: 366–375
   PubMedGoogle Scholar
• Irita K., Okabe Koga A., Yamakawa M., Yoshitake J.-I., Takahashi S. The effects of dichloroacetate on liver damage and circulating fuels in rats exposed to carbon tetrachloride. J. Gastroenterol. Hepatol. 1994; 9: 26–29
   PubMed Web of Science ®Google Scholar
• Lash L. H., Xu Y., Elfarra A. A., Duescher R. J., Parker J. C. Glutathi-one-dependent metabolism of trichloroethylene in isolated liver and kidney cells of rats and its role in mitochondrial and cellular toxicity. Drug Metab. Disp. 1995; 23: 846–853
   PubMed Web of Science ®Google Scholar
• Maronpot R. R., Anna C. H., Devereux T. R., Lucier G. W., Butterworth B. E., Anderson M. W. Considerations concerning the murine hepatocarcinogenicity of selected chlorinated hydrocarbons. Prog. Clin. Biol. Res. 1995; 391: 305–323
   PubMedGoogle Scholar
• Vaino H., Luinaenmaa K., KähöSnen M., Nickels J., Hietanen E., Marniemi J., Peltonen P. Hypolipidemia and peroxisome proliferation induced by phenoxyacetic acid herbicides in rats. Biochem. Pharmacol. 1983; 32: 2775–2779
   PubMed Web of Science ®Google Scholar
• Yamano T., Morita S. Hepatotoxicity of trichlorfon and dichlorvis in isolated rat hepatocytes. Toxicology 1992; 75: 69–77
   Google Scholar
• De Angelo A. B., Daniel F. B., Mc Millan L., Wernsing P., Savage R. E., Jr. Species and strain sensitivity to the induction of peroxisome proliferation by chloroacetic acids. Toxicol. Appl. Pharmacol. 1989; 101: 285–298
   PubMed Web of Science ®Google Scholar
• Chang L. W., Daniel F. B., De Angelo A. B. Analysis of DNA strand breaks induced in rodent liver in vivo, hepatocytes in primary culture, and a human cell line by chlorinated acetic acids and chlorinated acetaldehydes. Environ. Molec. Mutagen. 1992; 20: 277–288
   PubMed Web of Science ®Google Scholar
• Halpert J., Neal R. A. Cytochrome P-450-dependent metabolism of 1,1,2,2-tetrachloroethane to dichloroacetic acid in vitro. Biochem. Pharmacol. 1981; 30: 1366–1368
   PubMed Web of Science ®Google Scholar
• Rannug U., Gothe R., Wachtmeister C. A. The mutagenicity of chloroethylene oxide, chloroacetaldehyde, 2-chloroethanol and chloroacetic acid, conceivable metabolites of vinyl chloride. Chem. Biol. Interact. 1976; 12: 251–263
   PubMed Web of Science ®Google Scholar
• Hussain S., Oseterman-Golkar S. Comment on the mutagenic effectiveness of vinyl chloride metabolites. Chem. Biol. Interact. 1976; 12: 265–267
   PubMed Web of Science ®Google Scholar
• Weisberger E. K. Carcinogenicity studies on halogenated hydrocarbons. Environ. Health Perspect. 1977; 21: 7–16
   PubMed Web of Science ®Google Scholar
• Fischer G. W., Schneider P., Schuefler H. Zur mutagenitat von dichloracetaldehyd and 2,2-dichlor-1,1,-dihydroxy-athanphosphor sauremethyl ester, möglichen metaboliten des phosphorogavischer pestizides trichlorpon. Chem. Biol. Interact. 1977; 19: 205–213
   PubMedGoogle Scholar
• Lo Froth G. The mutagenecity of dichloroacetaldehyde. Naturforschung 1978; 33: 783–785
   Google Scholar
• Waskell L. A study of the mutagenicity of anesthetics and their metabolites. Mutation Res. 1978; 57: 141–153
   PubMed Web of Science ®Google Scholar
• Nestmann E. R., Chu I., Kowbel D. J., Matula T. I. Short-lived mutagen in salmonella produced by reaction of trichloroacetic acid and di-methyl sulfoxide. Can. J. Genet. Cytol. 1980; 22: 35–40
   PubMedGoogle Scholar
• Weightman A. J., Weightman A. L., Slater J. H. Toxic effects of chlorinated and brominated alkanoic acids on pseudomonas putida PP3: selection at high frequencies of mutations in genes encoding dehalogenases. Appl. Environ. Microbiol. 1985; 49: 1494–1501
   PubMed Web of Science ®Google Scholar
• Herbert V., Gardner A., Coleman N. Mutagenicity of dichloroacetate (DCA), an ingredient of the “cancer cure” pangamic acid (“vitamin B-15”). Blood 1978; 52: 252
   Google Scholar
• Herbert V., Gardner A., Coleman N. Dichloroacetate—a mutagen?. N. Engl. J. Med. 1979; 300: 625
   Web of Science ®Google Scholar
• Gelernt M. D., Hrbert V. Mutagenicity of diisopropylamine dichloroacetate, the “active constituent” of vitamin B15 (pangamic acid). Nutr. Cancer 1982; 3: 129–133
   PubMedGoogle Scholar
• De Marini D. M., Perry E., Shelton M. L. Dichloroacetic acid and related compounds: induction of prophage in E. coli and mutagenicity and mutation spectra in Salmonella TA100. Mutagenesis 1994; 9: 429–437
   PubMed Web of Science ®Google Scholar
• Nelson M. A., Bull R. J. Induction of strand breaks in DNA by trichloroethylene and metabolites in rat and mouse liver in viro. Toxicol. Appl. Pharmacol. 1988; 94: 45–54
   PubMed Web of Science ®Google Scholar
• Fusco J. C., Afshari A. J., George M. H., De Angelo A. B., Tice R. R., Salman T., Allen J. W. In vivo genotoxicity of dichloroacetic acid: evaluation with the mouse peripheral blood micronucleus assay and the single cell gel assay. Environ. Molec. Mutagen. 1996; 27: 1–9
   Web of Science ®Google Scholar
• Fox A. W., Yang X., Murli H., Lawlor T. E., Cifone M. A., Reno F. E. Absence of mutagenic effects of sodium dichloroacetate. Fundam. Appl. Toxicol. 1996; 32: 87–95
   PubMedGoogle Scholar
• Parrish J. M., Austin E. W., Stevens D. K., Kinder D. H., Bull R. J. Haloacetate-induced oxidative damage to DNA in the liver of male B6C3F1 mice. Toxicology 1996; 110: 103–111
   PubMed Web of Science ®Google Scholar
• Bruckner J. V., Mac Kenzie W. F., Muralidhara S., Luthra R., Kyle G. M., Accosta D. Oral toxicity of carbon tetrachloride: acute, subacute, and subchronic studies in rats. Fundam. Appl. Toxicol. 1986; 6: 16–34
   PubMedGoogle Scholar
• Binane S. G., Blackman C. F., House D. E. Effect of perchloroethylene and its metabolites on intercellular communication in clone 9 rat liver cells. J. Toxicol. Environ. Health 1996; 48: 427–437
   PubMed Web of Science ®Google Scholar
• Dierickx P. J. In vitro binding of acetic acid and its chlorinated derivatives by the soluble glutathione s-transferases from rat liver. Res. Commun. Chem. Pathol. Pharmacol. 1984; 44: 327–330
   PubMedGoogle Scholar
• Recknagel R. O., Glende E. A., Jr., Dolak J. A., Waller R. L. Mechanisms of carbon tetrachloride toxicity. Pharmac. Ther. 1989; 43: 139–154
   PubMed Web of Science ®Google Scholar
• Larson J. L., Bull R. J. Species differences in the metabolism of trichloroethylene to the carcinogenic metabolites trichloroacetate and dichloroacetate. Toxicol. Appl. Pharmacol. 1992; 115: 278–285
   PubMed Web of Science ®Google Scholar
• Lash L. H., Xu Y., Elfarra A. A., Deuscher R. J., Parker J. C. Glutathi-one-dependent metabolism of trichloroethylene in isolated liver and kidney cells of rats and its role in mitochondrial and cellular toxicity. Drug Metab. Disp. 1995; 23: 846–853
   PubMed Web of Science ®Google Scholar
• Irani K., Xia Y., Zweier J. L., Sollot S. J., Der C. J., Fearon E. R., Sundaresan M., Finkel T., Goldschmidt-Clermont P. J. Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts. Science 1997; 275: 1649–1652
   PubMed Web of Science ®Google Scholar
• Katz R., Tai C. N., Diener R. M., Mc Connell R. F., Semonick D. E. Dichloroacetate, sodium: 3-month oral toxicity studies in rats and dogs. Toxicol. Appl. Pharmacol. 1981; 57: 273–287
   PubMed Web of Science ®Google Scholar
• Stacpoole P. W., Harwood H. G., Jr., Cameron D. F., Curry S. H., Samuelson D. A., Cornwell P. E., Sauberlich H. E. Chronic toxicity of dichloroacetate: possible relation to thiamine deficiency in rats. Fundam. Appl. Toxicol. 1990; 14: 327–337
   PubMedGoogle Scholar
• Hodgkinson A. Oxalic Acid in Biology and Medicine. Academic Press, San Diego 1977; 52–61
   Google Scholar
• Yount E. A., Felten S. Y., O'Connor B. L., Peterson R. G., Powell R. S., Yum M. N., Harris R. A. Comparison of the metabolic and toxic effects of 2-chloroproprionate and dichloroacetate. J. Pharmacol. Exp. Therap. 1982; 222: 501–508
   PubMed Web of Science ®Google Scholar
• Linder R. E., Klinfelter G. R., Strader L. F., Suarez J. D., Dyer C. J. Acute spermatogenic effects of bromoacetic acids. Fundam. Appl. Toxicol. 1994; 22: 422–430
   PubMedGoogle Scholar
• Toth G. P., Kelty K. C., George E. L., Read E. J., Smith M. K. Adverse male reproductive effects following synchronic exposure of rats to sodium dichloroacetate. Fundam. Appl. Toxicol. 1992; 19: 57–63
   PubMedGoogle Scholar
• Cosby N. C., Dukelow W. R. Toxicology of maternally ingested trichloroethylene (TCE) on embryonal and fetal development in mice and of TCE metabolites on in vitro fertilization. Fundam. Appl. Toxicol. 1992; 19: 268–274
   PubMedGoogle Scholar
• Smith M. K., Randall J. L., Read E. J., Stober J. A. Teratogenic activity of trichloroacetic acid in the rat. Teratology 1989; 40: 445–451
   PubMedGoogle Scholar
• Epstein D. L., Noeln G. A., Randall J. R., Christ S. A., Read E. J., Stober J. A., Smith M. K. Cardiopathic effects of dichloroacetate in the fetal Long-Evans rat. Teratology 1992; 46: 225–235
   PubMedGoogle Scholar
• Bernstine J. B., Meyer A. E. Passage of metabolites of chloral hydrate into amniotic fluid. Proc. Soc. Exp. Biol. Med. 1953; 84: 456–457
   PubMed Web of Science ®Google Scholar
• Kerbey A. L., Randle P. J., Cooper R. H., Whitehouse S., Pask H. T., Denton R. M. Regulation of pyruvate dehydrogenase in rat heart. Biochem. J. 1976; 154: 327–347
   PubMed Web of Science ®Google Scholar
• Kurlemann G., Paetzke I., Mohler H., Masur H., Schuierer G., Weglage J., Koch H. G. Therapy of complex I deficiency: peripheral neuropathy during dichloroacetate therapy. Eur. J. Pediatr. 1995; 154: 928–932
   PubMed Web of Science ®Google Scholar
• Goldberg S. J., Lebowitz M. D., Graver E. J., Hicks S. An association of human congenital cardiac malformations and drinking water contaminants. J. Am. Coll. Cardiol. 1990; 16: 155–164
   PubMed Web of Science ®Google Scholar
• Yan Z., Henderson G. N., James M. O., Stacpoole P. W. Determination of dichloroacetate and its metabolites in human plasma by gas chromatography–mass spectrometry. J. Chromatogr. B 1997; 703: 75–84
   PubMed Web of Science ®Google Scholar
• Hietaven E., Laitinen M., Lang M., Vainio H. Inducibility of mucosal drug-metabolizing enzymes of rats fed on a cholesterol-rich diet by poly-chlorinated biphenyl, 3-metaylcholanthrene and phenobarbitone. Pharmacology 1975; 13: 287–296
   PubMed Web of Science ®Google Scholar
• Loub W. D., Wattenberg L. W., Davis D. W. Aryl hydrocarbon hydroxylase induction in rat tissues by naturally occurring indoles of cruciferous plants. J. Natl. Cancer. Inst. 1975; 54: 985–988
   PubMed Web of Science ®Google Scholar
• Wade A. E., Wu B., Lee J. Nutritional factors affecting drug-metabolizing enzymes of the rat. Biochem. Pharmacol. 1975; 24: 785–789
   PubMed Web of Science ®Google Scholar
• Abbott V., Deloria L., Guenther T., Jeffery E., Kotake A., Nerland D., Mannering G. Comparison of hepatic microsomal drug-metabolizing systems from rats fed crude and purified diets. Drug Metab. Disp. 1976; 4: 215–222
   PubMed Web of Science ®Google Scholar
• Hoensch H., Woo C. H., Raffin S. B., Schmid R. Oxidative metabolism of foreign compounds in rat small intestine: cellular localization and dependence on dietary iron. Gastroenterology 1976; 70: 1063–1070
   PubMed Web of Science ®Google Scholar
• Hopkins G. J., West C. E. Effects of dietary fats on pentobarbitone-induced sleeping times and hepatic microsomal cytochrome P-450 in rats. Lipids 1976; 11: 736–740
   PubMed Web of Science ®Google Scholar
• Korsrud G. O., Kuiper-Goodman T., Hasselager E., Grice H. C., Mc Laughlan J. M. Effects of dietary protein level on carbon tetrachloride-induced liver damage in rats. Toxicol. Appl. Pharmacol. 1976; 37: 1–12
   PubMed Web of Science ®Google Scholar
• Laitinen M., Hietanen E. The copper induced modification of duodenal biotransformation reactions in rats during fat deficiency. Acta Pharmacol. Toxicol. 1978; 43: 363–367
   PubMedGoogle Scholar
• Past M. R., Cook D. E. Effect of diabetes on rat liver cytochrome P-450. Evidence for a unique diabetes-dependent rat liver cytochrome P-450. Biochem. Pharmacol. 1982; 31: 3329–3334
   PubMed Web of Science ®Google Scholar
• Pascoe G. A., Sakai-Wong J., Soliven E., Correia M. A. Regulation of intestinal cytochrome P450 and heme by dietary nutrients. Biochem. Pharmacol. 1983; 32: 3027–3035
   PubMed Web of Science ®Google Scholar
• Wade A. E., White R. A., Walton L. C., Bellows J. T. Dietary fat—a requirement for induction of mixed-function oxidase activities in starved-refed rats. Biochem. Pharmacol. 1985; 34: 3747–3754
   PubMed Web of Science ®Google Scholar
• Williams M. T., Pendleton L. Effects of inhibitors of RNA and protein synthesis on hepatic microsomal cytochrome P-450 concentration in fasted and fed rats. Biochem. Pharmacol. 1985; 34: 3661–3665
   PubMed Web of Science ®Google Scholar
• Van Veld P. A., Vetter R. D., Lee R. F., Patton J. S. Dietary fat inhibits the intestinal metabolism of the carcinogen benzo[a]pyrene in fish. J. Lipid Res. 1987; 28: 810–817
   PubMed Web of Science ®Google Scholar
• Amelizad Z., Narbonne J. F., Wolf C. R., Robertson L. W., Oesch F. Effect of nutritional imbalances on cytochrome P-450 isozymes in rat liver. Biochem. Pharmacol. 1988; 37: 3245–3249
   PubMed Web of Science ®Google Scholar
• Clinton S. K., Visek W. J. Wheat bran and the induction of intestinal benzo(a)pyrene hydrorylase by dietary benzo(a)pyrene. J. Nutr. 1989; 119: 395–402
   PubMed Web of Science ®Google Scholar
• Rosenberg D. W. Dietary modulation of cytochrome P450 in the small intestinal epithelium. Pharmacology 1991; 43: 36–46
   PubMed Web of Science ®Google Scholar
• Nakajima T., Koyama Y., Sato A. Dietary modification of metabolism and toxicity of chemical substances with special reference to carbohydrate. Biochem. Pharmacol. 1982; 31: 1005–1011
   PubMed Web of Science ®Google Scholar
• De Krey G. K., Baecher-Steppan L., Deyo J. A., Smith B., Kerkvliet N. I. Polychlorinated biphenyl-induced immune suppression: castration, but not adrenalectony or RU 38486 treatment, partially restores the suppressed cytotoxic T lymphocyte response to alloantigen. J. Pharmacol. Exp. Therap. 1993; 267: 308–315
   PubMed Web of Science ®Google Scholar
• Pruett S. B., Ensley D. K., Crittenden P. L. The role of chemical-induced stress responses in immuno-suppression: a review of quantitative associations and cause-effect relationships between chemical-induced stress responses and immunosuppression. J. Toxicol. Environ. Health 1993; 39: 163–192
   PubMed Web of Science ®Google Scholar